Intrinsic Value of S&P & Nasdaq Contact Us

Abeona Therapeutics Inc. ABEO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$56.81
+994.6%
Analyst Price Target
$17.00
+227.6%

Stock Statistics — ABEO

Abeona Therapeutics Inc. (ABEO) has a market capitalization of $296.08M and trades at $5.19. The 52-week range is 3.93-7.54.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 3.9, Earnings Per Share (EPS) of $1.34, annual revenue of $5.82M.

The stock has a beta of 1.21, operates in the Healthcare sector.

Trading Data
Current Price$5.19
52-Week Range3.93-7.54
Volume1.13M
Avg Volume (30D)1.28M
Market Cap$296.08M
Beta (1Y)1.21
Company
IPO Date1980-09-19
Employees136
CEOVishwas Seshadri
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS00289Y2063
CUSIP00289Y107
Income (Latest Year)
Revenue$5.82M
Gross Profit$4.29M
EBITDA$-85.89M
Operating Income$-89.45M
Net Income$71.18M
EPS$1.34
EPS Diluted$1.01
Shares Outstanding$52.95M
Balance Sheet (Latest Year)
Total Assets$219.57M
Current Assets$204.91M
Cash & ST Investments$191.4M
Total Liabilities$60.35M
Total Debt$24.97M
Net Debt$-53.47M
Total Equity$159.22M
Debt / Equity0.16
Valuation Ratios
P/E Ratio3.9
P/S Ratio50.87
P/B Ratio1.86
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message